i think ohm's post #137914 has examples and links showing
i think ohm's post #137914 has examples and links showing there can be tentative decisions in a binding arbitration. it might be different state to state and i think this is also part of what the contract agreement between cytodyn and Amarex outlines as to how an arbitration is structured.
Not sure why this is important. the discovery and hearings have not happened yet and the stage when the arbitrator decides this is a year away. this could get resolved any time. my guess is that the lawyers for Amarex will make a recommendation to Amarex, NSF and the liability insurance company as to the amount they could end up paying and the likelihood of that happening after discovery. Amarex, NSF and the liability insurer will likely decide if they want to let this go all the way to an arbitrators decision or limit the risk sooner for less cost to them if they feel there is a good chance this will cost them a lot more later on. Cytodyn may want to take a settlement sooner for less at the advice of their lawyers who will give their opinion on the amount and likelihood that they will be awarded a favorable arbitration decision.
The rules of arbitration are just about the process, what matters to us investors is the likelihood Cytodyn will get a favorable outcome, when they will get it and how much it is. Cytodyn might really want the cash sooner and a smaller amount. thy might not have any urgency and will wait to get the maximum they can and risk an unfavorable arbitration decision.
either way, who cares if an arbitrator gives a tentative judgement in a binding arbitration? i don't.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Top 5 Most Recently Viewed Articles
Leadership Transition at Tourmaline Bio Tourmaline Bio, Inc. (NASDAQ:TRML) has recently revealed a significant change within its leadership. Dr. Yung Chyung, the Chief Medical Officer (CMO), is set to resign from his post effective at the end of October. This announcement took place in a recent filing, highlighting the company's commitment to transparency as it reshapes...
Continue Reading
Compugen to Showcase Groundbreaking Research in Cancer Immunotherapy Compugen Ltd. (Nasdaq: CGEN), a leading force in clinical-stage cancer immunotherapy, has announced an exciting opportunity to present at the upcoming Single Cell Genomics 2025 Conference. This event, scheduled for September 15-17, highlights advancements in genomics and how it intertwines with cancer...
Continue Reading
Transformational Growth of Salesforce Stock Over the past 15 years, Salesforce (NYSE: CRM) has emerged as a powerhouse in the tech industry, consistently surpassing market expectations. With an impressive average annual return rate of 22.25%, it has outperformed the broader market by 10.15% on an annualized basis. As of now, the company's market capitalization stands at...
Continue Reading
Infosys and AGCO Team Up for IT and HR Transformation Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz. Infosys (NSE: INFY), a global leader in next-generation digital services and consulting, has announced the continuation of its strategic partnership with AGCO Corporation (NYSE:...
Continue Reading
Growth of Europe's Contract Furniture Market The contract furniture and furnishing market in Europe is on the verge of a substantial transformation, anticipating an impressive growth of USD 4.75 billion from 2024 to 2028. The compound annual growth rate (CAGR) is expected to be close to 5.1% during this forecast period. This expansion is mainly driven by the increasing...
Continue Reading
